Joseph M Mylotte1, Jessica Keagle. 1. Department of Medicine, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14215, USA. Mylotte@buffalo.edu
Abstract
OBJECTIVES: To evaluate previously described antibiotic use and cost indicators in community nursing homes to determine whether they may be useful as benchmarks and to evaluate the association between functional status, infection occurrence, and antibiotic use. DESIGN: Retrospective observational study. SETTING: Eleven proprietary long-term care facilities owned by one company. PARTICIPANTS: Only facility-specific cumulative data were used. MEASUREMENTS: Antibiotic use and cost indicators (incidence of antibiotic use, antibiotic utilization ratio, cost of antibiotics per resident care day (RCD), and cost per antibiotic day), infection rates, and functional status as measured using the case-mix index (CMI) of the Resource Utilization Groups II system. Mean yearly values for each measure were calculated for each facility. RESULTS: There was significant variation in all of the antibiotic indicators between the 11 nursing homes, but there was no correlation between mean facility CMI and infection rate. However, there was a trend toward a significant correlation between mean facility CMI and mean facility incidence of antibiotic use, antibiotic utilization rate, and cost per RCD. Variation in mean facility infection rate explained 66% of the variation in mean facility incidence of antibiotic use (P<.001). In a multivariate analysis, mean facility infection rate (P=.003) and mean facility CMI (P=.046) were predictors of mean incidence of antibiotic use and explained 83% of the variation in dependent variable. CONCLUSION: The significant variation in mean antibiotic use and cost indicators between the 11 study facilities suggests that these indicators may be useful as benchmarks for quality-improvement efforts. For the first time, objective evidence is provided demonstrating the influence of functional status on antibiotic use in the nursing home setting.
OBJECTIVES: To evaluate previously described antibiotic use and cost indicators in community nursing homes to determine whether they may be useful as benchmarks and to evaluate the association between functional status, infection occurrence, and antibiotic use. DESIGN: Retrospective observational study. SETTING: Eleven proprietary long-term care facilities owned by one company. PARTICIPANTS: Only facility-specific cumulative data were used. MEASUREMENTS: Antibiotic use and cost indicators (incidence of antibiotic use, antibiotic utilization ratio, cost of antibiotics per resident care day (RCD), and cost per antibiotic day), infection rates, and functional status as measured using the case-mix index (CMI) of the Resource Utilization Groups II system. Mean yearly values for each measure were calculated for each facility. RESULTS: There was significant variation in all of the antibiotic indicators between the 11 nursing homes, but there was no correlation between mean facility CMI and infection rate. However, there was a trend toward a significant correlation between mean facility CMI and mean facility incidence of antibiotic use, antibiotic utilization rate, and cost per RCD. Variation in mean facility infection rate explained 66% of the variation in mean facility incidence of antibiotic use (P<.001). In a multivariate analysis, mean facility infection rate (P=.003) and mean facility CMI (P=.046) were predictors of mean incidence of antibiotic use and explained 83% of the variation in dependent variable. CONCLUSION: The significant variation in mean antibiotic use and cost indicators between the 11 study facilities suggests that these indicators may be useful as benchmarks for quality-improvement efforts. For the first time, objective evidence is provided demonstrating the influence of functional status on antibiotic use in the nursing home setting.
Authors: Elisabeth Broex; Boudewijn Catry; Katrien Latour; Karl Mertens; Vanessa Vankerckhoven; Arno Muller; Rudi Stroobants; Peter Zarb; Herman Goossens; Béatrice Jans Journal: Drugs Aging Date: 2011-10-01 Impact factor: 3.923
Authors: Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson Journal: Infect Control Hosp Epidemiol Date: 2008-09 Impact factor: 3.254
Authors: H J Appaneal; A R Caffrey; V V Lopes; V Mor; D M Dosa; K L LaPlante; T I Shireman Journal: J Hosp Infect Date: 2021-02-05 Impact factor: 3.926
Authors: Charles D Phillips; Omolola Adepoju; Nimalie Stone; Darcy K McMaughan Moudouni; Obioma Nwaiwu; Hongwei Zhao; Elizabeth Frentzel; David Mehr; Steven Garfinkel Journal: BMC Geriatr Date: 2012-11-23 Impact factor: 3.921
Authors: Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson Journal: Am J Infect Control Date: 2008-09 Impact factor: 2.918